Status:
COMPLETED
Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients With CSFP
Lead Sponsor:
RenJi Hospital
Conditions:
ST Segment Elevation Myocardial Infarction
Coronary Slow Flow Phenomenon
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
The study intends to evaluate the efficacy of different medicine delivering by targeted perfusion catheter in coronary administration on coronary blood flow in STEMI patients with CSFP.
Detailed Description
The goal of STEMI therapy is to successfully restore epicardial blood flow. PCI has been documented as being the most effective method for restoration of epicardial blood flow. However, stenting does ...
Eligibility Criteria
Inclusion
- Patents with myocardial infarction who have symptom onset within 12h before randomization; ECG: ≥2 mm ST-segment elevation in 2 contiguous precordial leads or ≥1 mm ST-segment elevation in 2 contiguous extremity leads ; Corrected TIMI frame counted (cTFC) measured from the final angiographic imaging after PCI exceeding 40 frames; Signed informed consent form prior to trial participation.
Exclusion
- Coronary artery bypass surgery (CABG) history; Failed in stents implanting; Severe heart failure; Cardiogenic shock.
Key Trial Info
Start Date :
August 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2017
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT03296670
Start Date
August 1 2015
End Date
August 31 2017
Last Update
March 12 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ren Ji Hospital Afflited to School of Medicine, Shanghai Jiao Tong University
Shanghai, China